治疗晚期前列腺癌新药——cabazitaxel
被引量:3
摘要
Cabazitaxel是一种用于治疗晚期前列腺痛的新药,由赛诺菲-安万特公司研制,2010年6月获美国FDA批准上市。该药是紫杉烷类化合物……1,分子式C45H57NO14C3H60,相对分子质量为894.01,结构式见图1。笔者将从药理学、药动学、临床试验和不良反应等方面对该药进行介绍。
出处
《中国药学杂志》
CAS
CSCD
北大核心
2011年第22期1773-1774,共2页
Chinese Pharmaceutical Journal
参考文献3
-
1DIRK S, PETER V E, JIM C. Castration-refractory prostate cancer: new drugs in the pipeline [J]. Adv Ther, 2010, 27(5) : 285-296.
-
2FDA. Label approved on 6/17/2010 for JEVTANA, NDA no. 201023 [ EB/OL ]. http://www, aecessdata, fda. gov/drugsatfda_docs/label/ 2010/2010231bl. pdf.
-
3SARTOR A O, OUDARD S, OZGUROGLU M, et al. Cabazitaxel or mitoxantrone with prednisone in patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel : final results of a multinational phase Ⅲ trial ( TROPIC ) [ abstract no. 9] [C]. 2010 ASCO Genitourinary Cancers Symposium. San Francisco, Califbrnia. 2010.
同被引文献43
-
1FDA. Label approved on 6/17/2010 for JEVTANA , NDA no.201023[EB/OL].[2012-03-27].http://www.Accessda- ta.fda.gov/drugsatfda_docs/label/2010/2010231bl.pdf.2010.
-
2Didier E, Oddon G, Pauze D, et al. Process for preparing derivatives of the taxoid .family: US, 5962705[P].1999- 10-05.
-
3Bouchard H, Bourzat JD, Commeron A. Methods of treat- ing cell lines expressing multidrug resistance P-glycopro- tein : US, 6372780[P].2002-04-06.
-
4伯查德H,伯尔萨特JD,科莫康A,等.新型紫杉化合物、其制备方法及其药物组合物:中国,1179776[P].1997-05-21.
-
5张伟中,张爱平,王权勇,等.一种卡巴他赛的制备方法:中国,102311410A[P].2012-01-11.
-
6BOUCHARD H, BOURZAT JD, COMMERON A. Methods of treating cell lines expressing muhidrug resistance P-glycoprotein: US, 6372780 [ P]. 2002 - 04 - 06.
-
7OUDARD S. TROPIC : phase III trial of cabazitaxel for the treat- ment of metastatic castration-resistant prostate cancer[ J]. Future Oncol,2011,7 (4) :497 - 506.
-
8PETRYLAK DP, TANGEN CM, HUSSAIN MH, et al. Docetax- el and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer [ J ]. N Engl J Med, 2004,351 (15) :1513 - 1520.
-
9BERRY DL, MO INPOUR CM, JIANG CS, et al. Quality of life and pain in advanced stage prostate cancer : results of a Southwest Oncology Group randomized trial comparing docetaxel and estra- mustine to mitoxantrone and prednisone [ J ]. J Clin Oncol, 2006, 24(18): 2828-2835.
-
10MICHIELSEN DP, BRAECKMAN JG, DENIS L. Cabazitaxel for the treatment of prostate cancerI J]. Expert Opin Pharmaeother, 2001,12(6) :977 -982.
引证文献3
-
1夏彪,邵波,杨巧宾,李勤耕.卡巴他赛关键中间体7β,10β-二甲氧基-10-脱乙酰巴卡汀Ⅲ的合成新方法[J].中国药房,2013,24(1):47-48. 被引量:4
-
2王春燕,俞明远,提文利,张义兵.卡巴他赛的合成进展[J].中国新药杂志,2014,23(15):1779-1785. 被引量:2
-
3冯菊,任凤英,杨晨,李江红,汪锡佳,陈林,石克金.高效液相色谱法测定卡巴他赛注射液的有关物质[J].中国药房,2018,29(9):1209-1212.
二级引证文献4
-
1王春燕,俞明远,提文利,张义兵.卡巴他赛的合成进展[J].中国新药杂志,2014,23(15):1779-1785. 被引量:2
-
2徐越,张富荣,胡春.卡巴他赛合成路线图解[J].中国药物化学杂志,2015,25(1):74-76.
-
3李磊.7β,10β-二甲氧基-10-DABⅢ的合成路线综述[J].广州化工,2016,44(24):21-23.
-
4冯菊,任凤英,杨晨,李江红,汪锡佳,陈林,石克金.高效液相色谱法测定卡巴他赛注射液的有关物质[J].中国药房,2018,29(9):1209-1212.
-
1FDA批准前列腺癌新疗法[J].齐鲁药事,2010(8):463-463. 被引量:1
-
2赛诺菲-安万特前列腺癌新药CabazitaxelⅢ期临床试验结果公布[J].中国医药导刊,2010,12(3):462-462.
-
3赵玉凤.抗前列腺癌新药——Cabazitaxel[J].中国药学杂志,2011,46(6):477-478.
-
4化疗药物cabazitaxel可延长转移性前列腺癌患者的总生存期[J].药学进展,2010,34(12).
-
5上市新药[J].世界临床药物,2012,33(11).
-
6王易,刘文杰,宗在伟,杜有国.卡巴他赛合成路线图解[J].中国医药工业杂志,2014,45(11):1090-1093. 被引量:1
-
7刘敬松,李晔,宋伟,于相国,宁玻.尼美舒利治疗前列腺痛160例[J].医药导报,2006,25(6):544-545. 被引量:4
-
8汤华琴.前列腺癌治疗药——Jevtana[J].齐鲁药事,2010,29(11):701-702.
-
9陈晶,李杏翠,张立军,杜小莉.抗晚期乳腺癌新药——甲磺酸艾日布林[J].中国药学杂志,2011,46(23):1855-1856. 被引量:1
-
10徐静雯,吴岑,沈继伟,张慧娟,左代英,李增强.新型微管抑制剂Yf9b能够诱导Hela细胞G2/M期阻滞和凋亡[J].沈阳药科大学学报,2017,34(1):71-78. 被引量:1